Trial Details
WITHDRAWNBasic Information
| Clinical ID | c4535 |
|---|---|
| Identifier | NCT00358683 |
| Trial Title | A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Certolizumab pegol |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2007-11 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |